Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes

Diabetes Care. 2009 Jun;32(6):1046-8. doi: 10.2337/dc08-2061. Epub 2009 Mar 5.

Abstract

Objective: To study the association between peri-conceptional A1C and serious adverse pregnancy outcome (congenital malformations and perinatal mortality).

Research design and methods: Prospective data were collected in 933 singleton pregnancies complicated by type 1 diabetes.

Results: The risk of serious adverse outcome at different A1C levels was compared with the background population. The risk was significantly higher when peri-conceptional A1C exceeded 6.9%, and the risk tended to increase gradually with increasing A1C. Women with A1C exceeding 10.4% had a very high risk of 16%. Congenital malformation rate increased significantly at A1C above 10.4%, whereas perinatal mortality was increased even at A1C below 6.9%.

Conclusions: These results support recent guidelines of preconceptional A1C levels <7% in women with type 1 diabetes.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Mass Index
  • Chromosome Aberrations / statistics & numerical data*
  • Diabetes Mellitus, Type 1 / complications*
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Infant, Newborn
  • Perinatal Mortality*
  • Pregnancy
  • Pregnancy Complications / epidemiology*
  • Pregnancy Outcome / epidemiology*
  • Prospective Studies
  • Retrospective Studies
  • White People

Substances

  • Glycated Hemoglobin A